These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36617785)

  • 21. d-glutamate and Gut Microbiota in Alzheimer's Disease.
    Chang CH; Lin CH; Lane HY
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysbiosis and Alzheimer's Disease: A Role for Chronic Stress?
    Sharma VK; Singh TG; Garg N; Dhiman S; Gupta S; Rahman MH; Najda A; Walasek-Janusz M; Kamel M; Albadrani GM; Akhtar MF; Saleem A; Altyar AE; Abdel-Daim MM
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33946488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut Microbiota and Alzheimer's Disease: Pathophysiology and Therapeutic Perspectives.
    Li Y; Wang R; Li Q; Wang YJ; Guo J
    J Alzheimers Dis; 2021; 83(3):963-976. PubMed ID: 34366348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases.
    Spielman LJ; Gibson DL; Klegeris A
    Neurochem Int; 2018 Nov; 120():149-163. PubMed ID: 30114473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut Microbiota and Alzheimer's Disease: Experimental Evidence and Clinical Reality.
    Saha S; Singh S; Prasad S; Mittal A; Sharma AK; Chakrabarti S
    Curr Alzheimer Res; 2021; 18(10):787-801. PubMed ID: 34493184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Western diet as a trigger of Alzheimer's disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration.
    Więckowska-Gacek A; Mietelska-Porowska A; Wydrych M; Wojda U
    Ageing Res Rev; 2021 Sep; 70():101397. PubMed ID: 34214643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
    Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
    Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Microbiota-Gut-Brain Axis in Alzheimer's Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions.
    Murray ER; Kemp M; Nguyen TT
    Arch Clin Neuropsychol; 2022 Feb; 37(3):595-607. PubMed ID: 35202456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Gut Microbiota in Health and Alzheimer's Disease.
    Szablewski L
    J Alzheimers Dis; 2018; 62(2):549-560. PubMed ID: 29480188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of Potential Brain Microbiome in Alzheimer's Disease: Implications of Study Bias.
    Westfall S; Dinh DM; Pasinetti GM
    J Alzheimers Dis; 2020; 75(2):559-570. PubMed ID: 32310171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Environmental toxins and Alzheimer's disease progression.
    Vasefi M; Ghaboolian-Zare E; Abedelwahab H; Osu A
    Neurochem Int; 2020 Dec; 141():104852. PubMed ID: 33010393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of gut microbiota in obesity, type 2 diabetes and Alzheimer's disease.
    Naseer MI; Bibi F; Alqahtani MH; Chaudhary AG; Azhar EI; Kamal MA; Yasir M
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):305-11. PubMed ID: 24059313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Gut Microbe Dysbiosis on the Pathogenesis of Alzheimer's Disease (AD) and Related Conditions.
    Nafady MH; Sayed ZS; Abdelkawy DA; Shebl ME; Elsayed RA; Ashraf GM; Perveen A; Attia MS; Bahbah EI
    Curr Alzheimer Res; 2022; 19(4):274-284. PubMed ID: 35440296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut Microbiota Dysbiosis Induced by Decreasing Endogenous Melatonin Mediates the Pathogenesis of Alzheimer's Disease and Obesity.
    Zhang B; Chen T; Cao M; Yuan C; Reiter RJ; Zhao Z; Zhao Y; Chen L; Fan W; Wang X; Zhou X; Li C
    Front Immunol; 2022; 13():900132. PubMed ID: 35619714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal Flora Affect Alzheimer's Disease by Regulating Endogenous Hormones.
    Wu Y; Hang Z; Lei T; Du H
    Neurochem Res; 2022 Dec; 47(12):3565-3582. PubMed ID: 36309938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut Microbiome and Mycobiome Alterations in an In Vivo Model of Alzheimer's Disease.
    D'Argenio V; Veneruso I; Gong C; Cecarini V; Bonfili L; Eleuteri AM
    Genes (Basel); 2022 Aug; 13(9):. PubMed ID: 36140732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective.
    Fox M; Knorr DA; Haptonstall KM
    Ann N Y Acad Sci; 2019 Aug; 1449(1):3-24. PubMed ID: 31180143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diet Patterns, the Gut Microbiome, and Alzheimer's Disease.
    Fairley A; Stewart CJ; Cassidy A; Woodside JV; McEvoy CT
    J Alzheimers Dis; 2022; 88(3):933-941. PubMed ID: 35634849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbiota Alterations in Alzheimer's Disease: Involvement of the Kynurenine Pathway and Inflammation.
    Garcez ML; Jacobs KR; Guillemin GJ
    Neurotox Res; 2019 Aug; 36(2):424-436. PubMed ID: 31089885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Waste Clearance in the Brain and Neuroinflammation: A Novel Perspective on Biomarker and Drug Target Discovery in Alzheimer's Disease.
    Uchida K
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.